$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
儿童或青少年肺癌患者可以服用吉非替尼吗?
2025-10-19 11:44:20
Check Details
服用特罗凯多久产生耐药性?
2025-10-19 11:44:20
Check Details
奥希替尼一线治疗非小细胞肺癌
2025-10-19 11:44:20
Check Details
克唑替尼在经治ALK阳性肺癌患者中的疗效和安全性:大规模试验PROFILE 1005结果
2025-10-19 11:44:20
Check Details
阿法替尼治疗EGFR突变阳性非小细胞肺癌
2025-10-19 11:44:20
Check Details
克唑替尼治疗MET+透明细胞肉瘤的疗效和安全性
2025-10-19 11:44:20
Check Details
克唑替尼治疗ALK和ROS1双重排肺鳞状细胞癌病例报告
2025-10-19 11:44:20
Check Details
FDA批准色瑞替尼用于非小细胞肺癌的一线治疗
2025-10-19 11:44:20
Check Details
艾乐替尼非小细胞肺癌患者的二线用药
2025-10-19 11:44:20
Check Details
常规化疗对IIIA期非小细胞肺癌无效时,克唑替尼作为新辅助治疗方案
2025-10-19 11:44:20
Check Details
卡博替尼治疗ROS1融合基因非小细胞肺癌
2025-10-19 11:44:20
Check Details
克唑替尼靶向ALK治疗小儿间变性大细胞淋巴瘤和炎性肌纤维母细胞瘤
2025-10-19 11:44:20
Check Details
1
2
...
9102
9103
9104
9105
9106
9107
9108
...
10233
10234
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Fayuvi (rebisufligene etisparvovec-hopf/UX111) for MPS IIIA: AAV9 SGSH Gene Therapy, Cognition, and Safety
2
Ramosetron Hydrochloride Orally Disintegrating Tablets: A 5-HT3 Receptor Antagonist for Diarrhea-Predominant IBS
3
Finerenone (Kerendia) for Diabetic CKD and HF with LVEF≥40%: Albuminuria, Dosing, Hyperkalemia
4
Baxdrostat (Baxfendy) for Hypertension: Aldosterone Synthase Inhibition, Dosing, and Discontinuation Rules
5
Pixclara (Floretyrosine F-18/18F-FET) Glioma PET: Distinguishing Recurrence from Treatment-Related Change
6
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
7
Bexlutry (Lu-177 Dotatate) for SSTR-Positive GEP-NETs: PRRT Dosing and Safety Monitoring
8
Etrasimod for Ulcerative Colitis: 2mg Once Daily, Onset Timeline, and Safety Monitoring
9
Hibsago (Bepirovirsen) Japan Approval: CHB Functional Cure and B-Well Data Essentials
10
FDA Approves Isembyld (apitegromab-mstn), the World’s First Skeletal Muscle-Targeted Therapy for SMA
11
Post-Enzalutamide mCRPC: HRR/PARP, PSMA Radioligand, and Chemotherapy Sequencing
12
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management